Glucose lowering treatments and cardiovascular risk

被引：0
|
作者：
Bonnet, F. [1 ]
机构：
[1] Hop Sud, Serv Endocrinol Diabetol Nutr, Rennes, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2010年 / 14卷 / 09期
关键词：
Cardiovascular; Glucose lowering treatment; Diabetes; MYOCARDIAL-INFARCTION; MORTALITY; OUTCOMES; SULFONYLUREAS; PIOGLITAZONE; DISEASE; TRIAL;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：281 / 284
页数：4
相关论文
共 50 条
  • [31] Glucose and cardiovascular risk
    Fuchs, M
    Hoekstra, JBL
    Mudde, AH
    NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (05): : 192 - 199
  • [32] Primary prevention of cardiovascular diseases via lipid lowering treatments
    Klose, G
    INTERNIST, 1997, 38 (06): : 615 - 616
  • [33] The impact of glucose-lowering medications on cardiovascular disease
    Avogaro, Angelo
    De Kreutzenberg, Saula Vigili
    Fadini, Gian Paolo
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2018, 7 (01): : 13 - 17
  • [34] Cardiovascular Outcome Trials with Glucose-Lowering Drugs
    Thethi, Tina K.
    Bilal, Anika
    Pratley, Richard E.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (07)
  • [35] LEADER and the new 'cardiovascular' glucose-lowering agents
    Livingstone, Rachel
    Boyle, James G.
    Petrie, John R.
    PRACTICAL DIABETES, 2016, 33 (06) : 187 - 189
  • [36] Cardiovascular safety concerns of glucose-lowering drugs
    Scholze J.
    MMW - Fortschritte der Medizin, 2017, 159 (1) : 62 - 66
  • [37] The impact of glucose-lowering therapy on cardiovascular outcomes
    Standl, Eberhard
    Mueller, Martin
    Schnell, Oliver
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (03) : 401 - 411
  • [38] Cardiovascular outcome trials of glucose-lowering therapies
    Khunti, Kamlesh
    Davies, Melanie J.
    Seidu, Samuel
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (03) : 237 - 249
  • [39] Cardiovascular Outcome Trials with Glucose-Lowering Drugs
    Tina K. Thethi
    Anika Bilal
    Richard E. Pratley
    Current Cardiology Reports, 2021, 23
  • [40] Increased risk of death with intensive glucose lowering
    Reactions Weekly, 2008, 1206 (1) : 1 - 1
12345